The S&P/ASX 200 closed 48 points higher, up 0.68%.
The Index is up for a fifth consecutive session amid a risk-on session led by technology and retail stocks, Bank of Queensland shares tumble on a worse-than-expected FY23 result (and we break down everything you need to know), CSL shares finish flat on a rather lacklustre AGM, two brokers give their take on lithium and eyes on US PPI and FOMC tonight.
Let's dive in.
Wed 11 Oct 23, 4:17pm (AEST)
Enjoying the Evening Wrap? Sign up to get it sent directly to your inbox after every trading day.
The ASX 200 extends its win streak to five, up 2.9% from the 4 October low. The market continues to make V-shaped rallies off of extreme oversold levels – Like it has been all year. It's been able to muster up strength from levels where investors begin to think 'oh my god is something about to break,' to which nothing has yet to break. The Index is rallying into some key overhead resistance levels like 7,100 and the 50-day moving average, so let's how it behaves around these key areas.
Sector performance was very risk-on as Technology and Discretionary led to the upside. We'll talk more about underperforming sectors in the form of Healthcare (CSL's AGM) and Financials (Bank of Queensland FY23 results) below.
No major economic announcements. US PPI data is due tonight at 10:30 pm AEDT followed by FOMC minutes at 4:00 am.
CSL (ASX: CSL) finished 0.3% lower on Tuesday, reflecting a rather lacklustre AGM.
Reiterated FY24 guidance: Which was revenue growth of 9-11% and NPATA growth between 13-17%
A brief note on Vifor: Not much to be said about the $18bn kidney care business that was bought last October. The company said "our focus is on unlocking the value and the growth within this business – a business we are yet to fully leverage the value of the broader CSL network."
The three decade track record: CSL flexed its track record. All respect to this market darling.
Bank of Queensland (ASX: BOQ) dropped its not-so-great-but-widely-expected FY23 results today. I'll be breaking down a few things including: How it fared against broker expectations, short interest and intraday price action.
By the numbers:
Cash earnings of $450 million, down 8% from FY22
Below consensus expectations of $470 million (-4.3%)
Net interest margin of 1.69%, down 2 bps
Missed consensus expectations of 1.71%
Housing loan growth of -$0.7 billion, down 1%
Cash earnings per share of 68.4 cents, down 10%
Missed consensus expectations by 2-7%
Cash operating expenses of $1.0 billion, up 8%
FY24 dividend forecast of 67.5 cents per share
Missed consensus expectations by 5-9.5%
The results flagged some rather well-documented headwinds as banks must offer more attractive rates to bolster deposits while offering greater discounts to those seeking loans amid still-sticky inflation.
The outlook was rather dire:
"Slower credit growth whilst BOQ continues to prioritise economic return over volume growth in a highly competitive environment."
"We anticipate mortgage pricing will need to adjust to provide returns above banks cost of capital."
"Deposit competition to remain intense as industry Term Funding Facility refinancing continues."
But everyone was already bullish: All major brokers including Citi, Morgan Stanley, Macquarie, Goldman Sachs and JPMorgan were all Sell-rated on BOQ with price targets ranging from $5.0 to $5.60.
Why short interest is key: So everyone is bearish heading into the result (which came out a little worse than expected). But the other thing to note is how BOQ short interest has climbed from around 6% in July to 7.6% in October.
Why this matters: Stocks that have a high short interest tend to trade in a rather volatile fashion when such announcements drop. Some general examples include:
High short interest but results were better-than-expected: A major squeeze like Domino's Pizza during its FY23 results (opened -5.3% lower but finished that session 11.8% higher)
High short interest and results were bad: A gap down, followed by a brief short squeeze. The market will then decide on a direction.
Bank of Queensland was a good example of the latter.
Open: Gapped down around 2.0%. The candle charts show a brief spike to breakeven in the second minute of trade
The chop: The stock would chop around the $5.55 level for a long while. Though to around noon. The order book was extremely thick around $5.50 to $5.55
The break: It would finally give up this $5.50 level and close near worst levels of $5.35
Interesting news and movers
Trading higher
+5.6% SRG Global (SRG) – Contract award
+3.1% Syrah Resources (SYR) – Solar & Battery Update for Balama
+2.9% Argosy Minerals (AGY) – Rincon Project Update
+2.6% Lynas (LYC) – Goldman Sachs upgrade
Trading lower
-37.5% Kazia Therapeutics (KZA) – ASX delisting
-7.4% Bank of Queensland (BOQ) – Earnings
Morgan Stanley on lithium:
“We stay bearish on lithium here, forecasting China lithium carbonate price to fall to US$22,000 a tonne by 1Q24 and US$20,000 by 4Q24.”
“Upside risks: Outperforming EV volumes and underperforming supply on weakening margins would tighten the balance.. An El Nino event could cause heavy rainfall in the Atacama Desert , reducing output.”
UBS on lithium:
“With Chinese lithium carbonate futures prices now at ~RMB150,000/t, spodumene prices from the various PRA continue to fall.”
“We recently downgraded our average forecast for the remainder of FY24 to US$2,500/t, but note market consensus appears too high for PLS's 1H FY24 realised price.”
“Until the pricing cycle turns we continue to prefer IGO, with its low cost, high grade product and lagged contract structure offering some ST protection.”
Get the latest news and insights direct to your inbox
Create an account to receive our concise, data-driven post-market recap, sent directly to your inbox, every day.
Along with the Evening Wrap, you'll join 100k+ investors who receive our Morning Wrap and Weekend Newsletter.
Subscribe Now Sign Up FreeAlready have an account? Log in